SLC5A2 and heart failure: Three newly formed START criteria (the lack of mineralocorticoid receptor antagonists and SGLT-2 inhibitors in heart failure and the lack of osmotic laxatives for chronic constipation) accounted for most of the additional omissions, compared with START v2.